| Trial ID: | L4803 |
| Source ID: | NCT01055808
|
| Associated Drug: |
Insulins
|
| Title: |
Observational Study in Japanese Type 2 Diabetes Patients
|
| Acronym: |
INSIGHTS
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Insulins
|
| Outcome Measures: |
Primary: Changes in Health Related Quality of Life (ITR-QOL) in insulin treated type 2 diabetes at baseline and 12 weeks after a significant change in insulin treatment regimen, Baseline, 12 weeks | Secondary: Summarize by occurrence the reason for insulin treatment change at study entry, Baseline|Change in HbA1c at baseline and 12 weeks after a significant change in insulin treatment regimen, Baseline, 12 weeks|Change in treatment adherence at baseline and 12 weeks after a significant change in insulin treatment regimen, Baseline, 12 weeks|Change in DTSQ (Diabetes treatment satisfaction questionnaire) at baseline and 12 weeks after a significant change in insulin treatment regimen, Baseline, 12 weeks|Total daily dose of insulin, Baseline, over 12 weeks|Change in type of insulin product, Baseline, 12 weeks|Change from baseline in use of concomitant oral hypoglycemic drugs, Baseline, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Eli Lilly and Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
677
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2010-01
|
| Completion Date: |
2010-11
|
| Results First Posted: |
|
| Last Update Posted: |
2010-12-10
|
| Locations: |
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hyogo, 651-0086, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01055808
|
